Monoterpenes as regulators of malignant cell proliferation

Advances in Experimental Medicine and Biology

Volumn 401, Issue , 1996, Pages 137-146

  Hohl, Raymond J ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIMONENE; MEVALONIC ACID; MEVINOLIN; PROTEIN FARNESYLTRANSFERASE; RAS PROTEIN; TERPENE;

ANTINEOPLASTIC ACTIVITY; BONE MARROW CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CHOLESTEROL SYNTHESIS; CONFERENCE PAPER; ISOPRENYLATION; LEUKEMIA CELL LINE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0029814832     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4613-0399-2_11     Document Type: Conference Paper

References (43)

1. Igimi, H., Hisatsuga, T., and Nishimura M. The use of d-limonene as a dissolving agent in gallstones. Dig. Dis., 21:926-939, 1976.
2. Elegbede, J.A., Elson, C.E., Qureshi, A., Tanner, M.A., and Gould, M.N. Inhibition of DMBA-induced mammary cancer by the monoterpene d-limonene. Carcinogenesis, 5:661-664, 1984.
3. Elegbede, J.A., Elson, C.E., Tanner, M.A., Qureshi, A. and Gould, M.N. Regression of rat primary mammary tumors following dietary d-limonene. J. Natl. Cancer Inst., 76:323-325, 1986.
4. Elson, C.E., Maltzman, T.H., Boston, J.L., Tanner, M.A., and Gould, M.N. Anti-carcinogenic activity of d-limonene during the initiation and promotion/progression stages of DMBA-induced rat mammary carcinogenesis. Carcinogenesis, 9:331-332, 1988.
5. Maltzman, T.H., Hurt, L.M., Elson, C.E., Tanner, M.A., and Gould M.N. The prevention of nitrosomethylurea-induced mammary tumors by d-limonene and orange oil. Carcinogenesis, 10:781-783, 1989.
6. Wattenberg, L.W., Sparnns, V.L., and Barany, G. Inhibition of N-nitrosodiethylamine carcinogenesis in mice by naturally occuring organosulfu compounds and monoterpees. Cancer Res., 49:2689-2692, 1989.
7. Lin, F.K., Banerjee, M.R., and Cump, L.R. Cell cycle related hormone carcinogen interaction during chemical carcinogen induction of nodule-like mammary lesions in organ culture. Cancer Res., 36:1607-1614, 1976.
8. Mehta, R.G., and Moon, R.C. Characterization of effective chemopreventive agents in mammary gland in vitro using an initiation-promotion protocol. Anticancer Res., 11:593-596, 1991.
9. Russin, W.A., Hoesly, J.D., Elson, C.E., Tanner, M.A., and Gould M.N. Inhibition of rat mammary carcinogenesis by monoterpenoids. Carcinogenesis, 10:2161-2164, 1989.
10. Steele, V.E., Kelloff, G.J., Wilkinson, B.P., and Arnold, J.T. Inhibition of transformation in cultured rat tracheal epithelial cells by potential chemopreventive agents. Cancer Res., 50:2068-2074, 1990.
11. Kodama, R., Yano, T., Furukawa, K., Noda, K. and Ide, H. Studies on the metabolism of d-limonene (p-mentha-1,8-diene). IV Isolation and characterization of new metabolites and species differences in metabolism. Xenobiotica, 6:377-389, 1976.
12. Crowell, P.L., Lin, S., Vedejs, E., and Gould, M.N. Identification of circulating metabolites of the antitumor agent d-limonene capable of inhibiting protein isoprenylation and cell growth. Cancer Chemother Pharmacol 31:205-212, 1992.
13. Crowell, P.L, Elson C.E., Bailey, H.H., Elegbede, A., Haag, J.D., and Gould, M.N. Human metabolism of the experimental cancer therapeutic agent d-limonene. Cancer Chemother Pharmacol 35:31-37, 1994.
14. Crowell, P.J., Ren, Z., Lin, S., Vedejs, E., and Gould, M.N. Structure-activity relationships among monoterpene inhibitors of protein isoprenylation and cell proliferation. Biochem Pharmacol 47:1405-1415, 1994.
15. Ruch, R.J. and Sigler, K. Growth inhibition of rat liver epithelial tumor cells does not involve RAS plasma membrane association. Carcinogenesis 15:787-789, 1994.
16. Schulz, S., Buhling, F., and Ansorge, S. Prenylated proteins and lymphocyte proliferation: inhibition by d-limonene and related monoterpenes. Eur J Immunol 24:301-301, 1994.
17. Bronfen, J.H., Stark, J.M., and Crowell, P.L. Inhibition of human pancreatic carcinoma cell proliferation by perillyl alcohol. Proc Am. Assoc. Cancer Res. 35: 431, 1994. (abstr.)
18. Hohl, R.J. and Lewis, K. RAS expression in human leukemia is modulated differently by lovastatin and limonene. Blood 80:299a, 1992. (abstr.)
19. Barbacid, M. RAS Genes. Ann. Rev. Biochem. 56:779-827, 1987.
20. Bos, J.L. RAS Oncogenes in Human Cancer: A Review. Cancer Res., 49:4682-4689, 1989.
21. Kitayama, H., Sugimoto, Y., Matsuzak, T., Ikawa, Y., and Noda, M. A ras-related gene with transformation supressor activity. Cell, 56:77-84, 1989.
22. Chang, E.H., Furth, M.E., Scolnick, E.M. and Lowy, D.R. Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus. Nature, 297:478-483, 1982.
23. Chin, K.V., Ueda, K., Pastan, I., and Gottesman, M.M. Modulation of activity of the promoter of the human MDR1 gene by ras and p53. Science, 255:459-462, 1992.
24. Schafer, W.R., Kim, R., Sterne, R., Thorner, J., Kim, S-H., and Rine, J. Genetic and pharmacologic supression of oncogenic mutations in RAS genes of yeast and humans. Science, 245:379-385, 1989.
25. Hancock, J.F., Magee, A.I., Childs, J.E., and Marshall, C.J. All ras proteins are polyisoprenylated but only some are palmitoylated. Cell, 57:1167-1177, 1989.
26. Willumsen, B.M., Norris, K., Papageorge, A.G., Hubbert, N.L. and Lowy, D.L. Harvey murine sarcoma virus p21ras protein:biological and biochemical significance of the cysteine nearest the carboxy terminus. EMBO J., 3:2581-2585, 1984.
27. Endo, A., Kuroda, M., and Tsujita, Y. ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterol-genesis produced by Penicillium citrinum. J. Antibiot., 24:1346-1348, 1976.
28. Hohl, R.J., Mannickarottu, V., and Yachnin, S. The effect of alterations of hydroxymethylglutaryl coenzyme A reductase on the expression of the RAS oncogene. Clinical Research, 38:843A, 1990. (abstr.)
29. Hohl, R.J., Larson, R.A., Mannickarottu, V., and Yachnin, S. Inhibition of hydroxymethylglutaryl coenzyme A reductase activity induces a paradoxical increase in DNA synthesis in myeloid leukemia cells. Blood, 77:1064-1070, 1991.
30. ras farnesyl;protein transferase by Cys-AAX tetrapeptides. Cell 62:81-86, 1990.
31. Gibbs, J., Pompliano, D., Mosser, S., Rands, E., Lingham, R., Singh S., Scolnick, E. Kohl, N., and Oliff, A. Selective inhibition of farensyl-protein transferase blocks ras processing in vivo. J Biol Chem 268:7617-7620, 1993.
32. Kohl, N., Mosser, S., deSolms, S., Giuliani, E., Pompliano, D., Graham, S., Smith, R., Scolnick, E., Oliff, A., and Gibbs, J. Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor. Science 260:1934-1937, 1993.
33. James, G., Goldstein, J., Brown, M., Rawson, T., Somers, T., McDowell, R., Crowley, C., Lucas, B., Levinson, A., and Marsters, J. Benzodiazepine peptidomimetics: potent inhibitors of ras farnesylation in animal cells. Science 260:1937-1941, 1993.
34. Garcia, A.M., Rowell, C., Ackerman, K., Kowalczyk, J.J., and Lewis, M.D. Peptidomimetic inhibitors of ras farnesylation and function in whole cells. J Biol Chem 268:18415-18418, 1993.
35. 2X peptidomimetics. J Biol Chem 268:20695-20698, 1993.
36. Crowell, P.L., Chang, R.R., Ren, Z., Elson, C.E. and Gould, M.N. Selective inhibition of isoprenylation of 21-26 kDa proteins by the anticarcinogen d-limonene and its metabolites. J. Biol. Chem., 266:17679-17685, 1991.
37. Clegg, R.J., Middleton, B., Bell, C.D., and White, D.A. The mechanism of cyclic monoterpene inhibition of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase in vivo in the rat. J Biol Chem 257:2294-2299, 1982.
38. Jirtle, R.L., Haag, J.D., Ariazi, E.A., and Gould, M.N. Increased mannose 6-phosphate/insulin-like growth factor II receptor and transforming growth factor β1 levels during monoterpene-induced regression of mammary tumors. Cancer Res 53:3849-3852, 1993.
39. Schmidt, R.A., Schneider, C.J., and Glomset, J.A. Evidence for post-translational incorporation of a product of mevalonic acid into Swiss 3T3 cell proteins. J Biol Chem 259:10175-10180, 1984.
40. Ulsh, L.S., and Shih, T.Y. Metabolic turnover of human c-rasH p21 protein of EJ bladder carcinoma and its normal cellular and viral homologs. Mol Cell Biol 4:1647-1652, 1984.
41. Hohl, R.J., and Lewis K. Differential effects of monoterpenes and lovastatin on RAS processing. J Biol Chem 270:17508-17512, 1995.
42. Kawata, S., Nagase, T., Yamasaki, E., Ishiguro, H., and Matsuzwawa, Y. Modulation of the mevalonate pathway and cell growth by pravastatin and d-limonene in a human hepatoma cell line (Hep G2). Br J Cancer 69:1015-1020, 1994.
43. Raj, M., Kratz, D., Lewis, K., and Hohl, R.J. Effects of combinations of lovastatin and monoterpenes on ras processing. Proc of AACR 36:428, 1995. (abstr.)